Allspring Global Investments Holdings, LLC Chinook Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $59.4 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023
BUY
$21.53 - $26.8 $26,589 - $33,098
1,235 Added 38.13%
4,474 $103,000
Q4 2022

Jan 23, 2023
SELL
$18.63 - $27.35 $1,322 - $1,941
-71 Reduced 2.15%
3,239 $0
Q3 2022

Oct 26, 2022
BUY
$17.51 - $23.37 $57,958 - $77,354
3,310 New
3,310 $65,000
Q4 2021

Jan 28, 2022
BUY
$10.69 - $16.83 $127,467 - $200,680
11,924 New
11,924 $194,000

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email